Literature DB >> 23224327

Parental nutrient intake and risk of retinoblastoma resulting from new germline RB1 mutation.

Greta R Bunin1, Yimei Li, Arupa Ganguly, Anna T Meadows, Marilyn Tseng.   

Abstract

PURPOSE: We conducted a case-control study to examine the role of parents' nutrient intake before their child's conception in the child's risk of sporadic bilateral retinoblastoma, which results from a new germline RB1 mutation.
METHODS: Parents of 206 cases from 9 North American institutions and 269 friend and relative controls participated; fathers of 182 cases and 223 controls and mothers of 202 cases and 260 controls provided useable information in telephone interviews on their diet in the year before the child's conception. We also asked parents about supplements, a significant source of nutrients in users.
RESULTS: Father's intake of dairy-associated nutrients and his use of calcium supplements were associated with decreased risk, while his intake of copper, manganese, and vitamin E was associated with increased risk. Mother's use of multivitamins close to conception was associated with lower risk as was her intake of several micronutrients found in these supplements. In analyses to elucidate the primary factor from multiple correlated factors, the most robust findings were for father's calcium intake (adjusted OR = 0.46-0.63 for 700 mg increase) and calcium supplement use (OR = 0.35-0.41) and mother's multivitamin use (ORs 0.28-0.48).
CONCLUSIONS: There are few directly relevant studies but some data indirectly support the biologic plausibility of the inverse associations with father's calcium intake and mother's use of multivitamins; however, we cannot rule out contributions of bias, confounding, or chance. Our findings provide a starting point for further investigation of diet in the etiology of retinoblastoma and new germline mutation generally.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23224327      PMCID: PMC3557550          DOI: 10.1007/s10552-012-0120-x

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  28 in total

Review 1.  Antimutagenicity in cultured mammalian cells.

Authors:  Y Kuroda; A K Jain; H Tezuka; T Kada
Journal:  Mutat Res       Date:  1992-06       Impact factor: 2.433

2.  MTRR and MTHFR polymorphism: link to Down syndrome?

Authors:  Valerie B O'Leary; Anne Parle-McDermott; Anne M Molloy; Peadar N Kirke; Zachary Johnson; Mary Conley; John M Scott; James L Mills
Journal:  Am J Med Genet       Date:  2002-01-15

3.  Parental diet and risk of retinoblastoma resulting from new germline RB1 mutation.

Authors:  Greta R Bunin; Marilyn Tseng; Yimei Li; Anna T Meadows; Arupa Ganguly
Journal:  Environ Mol Mutagen       Date:  2012-06-25       Impact factor: 3.216

4.  Parental origin of mutations of the retinoblastoma gene.

Authors:  T P Dryja; S Mukai; R Petersen; J M Rapaport; D Walton; D W Yandell
Journal:  Nature       Date:  1989-06-15       Impact factor: 49.962

5.  Preferential germline mutation of the paternal allele in retinoblastoma.

Authors:  X P Zhu; J M Dunn; R A Phillips; A D Goddard; K E Paton; A Becker; B L Gallie
Journal:  Nature       Date:  1989-07-27       Impact factor: 49.962

6.  Reproducibility and validity of a semiquantitative food frequency questionnaire.

Authors:  W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer
Journal:  Am J Epidemiol       Date:  1985-07       Impact factor: 4.897

7.  Ascorbic acid protects against endogenous oxidative DNA damage in human sperm.

Authors:  C G Fraga; P A Motchnik; M K Shigenaga; H J Helbock; R A Jacob; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

9.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.

Authors:  S H Friend; R Bernards; S Rogelj; R A Weinberg; J M Rapaport; D M Albert; T P Dryja
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

10.  Pre- and postconception factors associated with sporadic heritable and nonheritable retinoblastoma.

Authors:  G R Bunin; A T Meadows; B S Emanuel; J D Buckley; W G Woods; G D Hammond
Journal:  Cancer Res       Date:  1989-10-15       Impact factor: 12.701

View more
  4 in total

1.  DNA methylation changes in the placenta are associated with fetal manganese exposure.

Authors:  Jennifer Z J Maccani; Devin C Koestler; E Andrés Houseman; David A Armstrong; Carmen J Marsit; Karl T Kelsey
Journal:  Reprod Toxicol       Date:  2015-05-15       Impact factor: 3.143

2.  Oxidative Stress and Polymorphism in MTHFR SNPs (677 and 1298) in Paternal Sperm DNA is Associated with an Increased Risk of Retinoblastoma in Their Children: A Case-Control Study.

Authors:  Shilpa Bisht; Bhavna Chawla; Rima Dada
Journal:  J Pediatr Genet       Date:  2018-07-11

3.  Parental Occupation and Risk of Childhood Retinoblastoma in Denmark.

Authors:  Negar Omidakhsh; Johnni Hansen; Beate Ritz; Anne L Coleman; Roberta McKean-Cowdin; Jorn Olsen; Julia E Heck
Journal:  J Occup Environ Med       Date:  2021-03-01       Impact factor: 2.306

4.  The Effects of Breastfeeding on Retinoblastoma Development: Results from an International Multicenter Retinoblastoma Survey.

Authors:  Jasmeen K Randhawa; Mary E Kim; Ashley Polski; Mark W Reid; Kristen Mascarenhas; Brianne Brown; Ido Didi Fabian; Swathi Kaliki; Andrew W Stacey; Elizabeth Burner; Caitlin S Sayegh; Roy A Poblete; Xunda Ji; Yihua Zou; Sadia Sultana; Riffat Rashid; Sadik Taju Sherief; Nathalie Cassoux; Juan Garcia; Rosdali Diaz Coronado; Arturo Manuel Zapata López; Tatiana Ushakova; Vladimir G Polyakov; Soma Rani Roy; Alia Ahmad; M Ashwin Reddy; Mandeep S Sagoo; Lamis Al Harby; Nicholas John Astbury; Covadonga Bascaran; Sharon Blum; Richard Bowman; Matthew J Burton; Nir Gomel; Naama Keren-Froim; Shiran Madgar; Marcia Zondervan; Jesse L Berry
Journal:  Cancers (Basel)       Date:  2021-09-24       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.